Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949515 · ClinicalTrials.gov registry record
Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility
A clinical trial of Acute ST Segment Elevation Myocardial Infarction, sponsored by Cardiovascular Research Foundation, New York.
- Completed
- Registry status
- 403
- Enrollment target
- 8
- Study locations
NCT05949515 is a study of Acute ST Segment Elevation Myocardial Infarction that has completed, run by Cardiovascular Research Foundation, New York. The registered enrollment target is 403 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT05949515, a study of Acute ST Segment Elevation Myocardial Infarction, has completed, sponsored by Cardiovascular Research Foundation, New York.
- COMPLETED
- Registry status
- 403 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).
Conditions Studied
Study Locations (8)
Florida
- Baptist Hospital of Miami, Inc and Its Miami Cardiac and Vascular Institute - Miami
- NCH Healthcare System - Naples
Ohio
- OhioHealth Research Institute - Columbus
- Avita Health - Galion
Michigan
- Oakwood Healthcare, Inc - Dearborn
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
New York
- Northwell Health, Inc - Great Neck
West Virginia
- St. Mary's Medical Center - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2023-07-31 |
| Est. Completion | 2024-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05949515
The ClinicalTrials.gov registry entry for NCT05949515 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cardiovascular Research Foundation, New York, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute ST Segment Elevation Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT05949515 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Florida, Ohio, Michigan.
Frequently Asked Questions
What is clinical trial NCT05949515 about?
NCT05949515 is a clinical study titled "Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility". The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).
What is the current status of trial NCT05949515?
This trial is currently completed. The enrollment target is 403 participants. The study started on 2023-07-31. Estimated completion is 2024-03-31.
What conditions does trial NCT05949515 study?
This clinical trial studies the following conditions: Acute ST Segment Elevation Myocardial Infarction.
Who is sponsoring clinical trial NCT05949515?
This trial is sponsored by Cardiovascular Research Foundation, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05949515 being conducted?
This trial has 8 study locations across Florida, Michigan, Minnesota, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.